#Dose

Prof Peter Hotez MD PhD

PeterHotez

1/10: My latest thinking after speaking with several important people on our current vaccine dilemma. 2/10: Right now, we just don't have sufficient vaccine supply to go around, and we

Ewan Birney

ewanbirney

There are some good and bad hot takes about the Oxford/AZ vaccine going around - I'd like to add my view which I hope is more light than heat. Context:

Steve White

NTVsSteveWhite

272,495 Nebraskans have been vaccinated. We learned during the trials that the vaccines are highly effective in preventing illness so serious that people need to be hospitalized. Now we have

Michael Mina

michaelmina_lab

UK has authorized AZ/Oxford vaccine. Importantly: UK is leading the way in taking a bold public health approach (vs individual health) to getting the population vaccinated - Prioritizing distribution of

Graham Boniface

graham_boniface

A thread about our new paper… A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keaa150/

Rajeev Venkayya MD

rvenkayya

THREADI created a simple table to illustrate the individual impact of the "flexible second dose timing" now recommended in the UK.Coincidentally, @bob_wachter & @ashishkjha just tackled the US policy question

Deepti Gurdasani

dgurdasani1

It's being widely reported that 1 dose of the Astra/Oxford vaccine reduces transmission by 67%. My understanding is that this is not what the paper shows, or what the authors

Eric Feigl-Ding

DrEricDing

BREAKING—Trump FDA just left final kick in the teeth—Pfizer will now ship fewer #COVID19 vaccine vials after it lobbied to count & **pay for** “extra” doses found in vials. Now

Will Hayward

WillHayCardiff

Wales is vaccinating fewer people than any other UK nation. Even one dose offers protection and can save lives.When you are restricting people from even low risk activities because "every

Stefan Kertesz, MD

StefanKertesz

1/I'm excited that Dr. @AjayManhapra is presenting on concerns about mandatory opioid taper for VA's MAT-VA journal club, based on our shared paper... he notes Human costs of mandatory and

Jim Reed

jim_reed

AstraZeneca responding to reports in Germany that Oxford vaccine might only be approved for under 65s: “Reports that efficacy is as low as 8% in adults over 65 are completely

Bob Wachter

Bob_Wachter

As expected, our @washingtonpost editorial today on the delayed second dose vaccine strategy has generated a vigorous and interesting dialogue. https://tinyurl.com/y7c6v9hz Here are my takeaways (a thread): 1/18 The debate

Céline Gounder, MD, ScM, FIDSA

celinegounder

1/ Should we give as many people one dose of the Pfizer and Moderna vaccines as possible? Or half as many people two doses of vaccine? It’s a data-free zone.https://twitter.com/CitizenCohn/status/1358075667573862401

Andrew Little

anthlittle

Two sort of contradictory thoughts on the one vs two dose argument, with the obvious caveat that I know very little about vaccines, but still based on some of my

Laurie Garrett

Laurie_Garrett

Talk in the UK (& Germany & Denmark) of using just 1 #COVID19 #vaccine dose/person for now, possibly providing boosters months later, is distressing. A quick thread follows.1.) @Pfizer has

Doug Campbell

TradeandMoney

I'm leaning toward joining team "one shot is enough". If you look at the Moderna vaccine, from day 13 or so, to day 27 (2nd dose should be on day

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.